Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AVPR1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PTP4A3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-96L14.7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RXFP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FAM163B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | UBE2J1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | PRLHR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MSL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | LAIR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |